Skip to main content

Peer Review reports

From: Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells

Original Submission
6 Oct 2019 Submitted Original manuscript
28 Oct 2019 Reviewed Reviewer Report - Zhichao Fan
11 Nov 2019 Reviewed Reviewer Report - Safiye Nese Atabey
19 Feb 2020 Author responded Author comments - HanHee Jo
25 Feb 2020 Reviewed Reviewer Report - Safiye Nese Atabey
29 Mar 2020 Author responded Author comments - HanHee Jo
Resubmission - Version 2
19 Feb 2020 Submitted Manuscript version 2
1 Apr 2020 Author responded Author comments - HanHee Jo
Resubmission - Version 3
1 Apr 2020 Submitted Manuscript version 3
Publishing
2 Apr 2020 Editorially accepted
19 Apr 2020 Article published 10.1186/s12885-020-06822-4

You can find further information about peer review here.

Back to article page